Premature termination codons (PTCs) account for 10 to 20% of genetic diseases in humans. The gene inactivation resulting from PTCs can be counteracted by the use of drugs stimulating PTC readthrough, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback